We are live on ! Find out more
DALS

DA32 Life Science Tech Acquisition Corp. Class A Common Stock
DALS

Delisted

DALS was delisted on the 28th of July, 2023.

Back to rankings

50 hedge funds and large institutions have $177M invested in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 15 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% more capital invested

Capital invested by funds: $171M → $177M (+$5.46M)

0% more funds holding

Funds holding: 50 → 50 (0)

0% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 5

53% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 15

Holders
50
Holders Change
–
Holders Change %
0%
% of All Funds
0.79%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
5
Increased
7
Reduced
15
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
WC
Wealthspring Capital
New York
+$3.01M
2
SFM
Spartan Fund Management
Canada
+$2.72M
3
AA
AQR Arbitrage
Connecticut
+$1.27M
4
DAM
Deltec Asset Management
New York
+$1.25M
5
CAC
Cowen and Company
New York
+$1.24M

Top Sellers

Rank Fund Capital Flow
1
MF
Magnetar Financial
Illinois
-$2.64M
2
JP Morgan Chase
JP Morgan Chase
New York
-$2.53M
3
Citadel Advisors
Citadel Advisors
Florida
-$1.46M
4
SCM
Segantii Capital Management
Hong Kong
-$1.01M
5
ETH
Exos TFP Holdings
New York
-$980K
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
26
Radcliffe Capital Management
Pennsylvania
$1.7M – – –
KL
27
KIM LLC
Kansas
$1.54M – – –
CAC
28
Cowen and Company
New York
$1.36M +$1.24M +121,816 +1,118%
Verition Fund Management
29
Verition Fund Management
Connecticut
$1.31M – – –
AIMCA
30
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$1.31M – – –
DAM
31
Deltec Asset Management
New York
$1.26M +$1.25M +122,367 New
Toronto Dominion Bank
32
Toronto Dominion Bank
Ontario, Canada
$1.14M – – –
COPPSERS
33
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$1.03M – – –
SG
34
StoneX Group
New York
$930K +$925K +90,598 New
Two Sigma Investments
35
Two Sigma Investments
New York
$821K – – –
Deutsche Bank
36
Deutsche Bank
Germany
$764K +$759K +74,425 New
ACA
37
Arena Capital Advisors
California
$708K – – –
KIM
38
Karpus Investment Management
New York
$554K – – –
GAM
39
Gritstone Asset Management
Maryland
$498K -$4.48K -439 -0.9%
D.E. Shaw & Co
40
D.E. Shaw & Co
New York
$472K – – –
KPF
41
K2 Principal Fund
Ontario, Canada
$405K +$403K +39,505 New
CSS
42
Cubist Systematic Strategies
Connecticut
$334K -$437K -42,805 -57%
PSC
43
Piper Sandler & Co
Minnesota
$257K – – –
TI
44
Tidal Investments
Wisconsin
$252K -$4.54K -445 -2%
RCM
45
Robinson Capital Management
Michigan
$252K -$4.54K -445 -2%
HF
46
HRT Financial
New York
$178K -$694 -68 -0.4%
PMEF
47
Point72 Middle East FZE
United Arab Emirates
$119K -$1.75K -171 -1%
UBS Group
48
UBS Group
Switzerland
$55.7K +$28.1K +2,753 +103%
CS
49
Clear Street
New York
$47.7K +$47.4K +4,645 New
TRCT
50
Tower Research Capital (TRC)
New York
$195 -$867 -85 -82%
1
2
3

DALS Hedge Fund Activity: Q2 2023 in Review

50 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) for Q2 2023, worth a combined $177M — up 3.2% from $171M a quarter earlier.

Fund positioning in DALS was balanced in Q2 2023: 5 funds opened new positions, 5 closed out, 7 added to existing stakes and 15 trimmed.

The largest buyer was Wealthspring Capital, adding an estimated $3.01M. The largest seller was Magnetar Financial, cutting an estimated $2.64M.

  • 50 institutional investors held DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) as of Q2 2023, unchanged from Q1 2023.
  • Funds reported $177M of DA32 Life Science Tech Acquisition Corp. Class A Common Stock stock for Q2 2023, up 3.2% quarter-over-quarter.
  • 5 funds opened new DA32 Life Science Tech Acquisition Corp. Class A Common Stock positions in Q2 2023 and 5 closed out, a net change of 0 holders.
  • The largest DA32 Life Science Tech Acquisition Corp. Class A Common Stock buyer in Q2 2023 was Wealthspring Capital, an estimated $3.01M added.
  • The largest DA32 Life Science Tech Acquisition Corp. Class A Common Stock seller in Q2 2023 was Magnetar Financial, an estimated $2.64M sold.

Based on aggregated 13F filings for Q2 2023.